Apria Healthcare Announces Fourth Quarter 2007 Earnings Conference Call.LAKE FOREST, Calif. -- AHG AHG antihemophilic globulin (coagulation factor VIII). AHG abbr. antihemophilic globulin AHG antihemophilic globulin (clotting factor VIII). (NYSE NYSE See: New York Stock Exchange :AHG), the nation's leading home healthcare company, will hold its quarterly conference call to discuss fourth quarter 2007 results Wednesday, February 6, at 11:15 a.m. Eastern Time (8:15 a.m. Pacific Time). This call is being webcast by CCBN CCBN Central Coast Bancorp CCBN Charles County Business Network and can be accessed at Apria Healthcare's web site at http://www.apria.com/. The webcast is also being distributed over CCBN's Investor Distribution Network to both institutional and individual investors. Individual investors can listen to the call through CCBN's individual investor center at www.fulldisclosure.com or by visiting any of the investor sites in CCBN's Individual Investor Network. Institutional investors can access the call via CCBN's password-protected event management site, StreetEvents (www.streetevents.com). Apria provides home healthcare products and services, including oxygen and respiratory equipment, home delivered respiratory medications, diabetic supplies and a broad range of home infusion therapies home infusion therapy The IV administration of therapeutics–analgesics, antibiotics, chemotherapy, parenteral nutrition–outside of a formal healthcare environment. See Hyperalimentation, Patient-controlled analgesics, TPN. and medical equipment. With approximately 500 branch and 32 infusion pharmacy locations nationwide, Apria serves 1.5 million patients annually throughout all 50 states. The Company is contracted with over 2,500 managed care organizations and serves patients covered by Medicare and Medicaid Medicare and Medicaid U.S. government programs in effect since 1966. Medicare covers most people 65 or older and those with long-term disabilities. Part A, a hospital insurance plan, also pays for home health visits and hospice care. as well. This release may contain statements regarding anticipated future developments that are forward-looking statements within the meaning of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. Results may differ materially as a result of the risk factors included in the Company's filings with the Securities and Exchange Commission and other factors over which the Company has no control. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion